Book Review: FDA in the Twenty-First Century:The Challenges of Regulating Drugs and New Technologies image

Journal of Law and the Biosciences, Vol. 3, Issue 1 (April 1, 2016)
Ryan Abbot, reviewing book edited by Holly Fernandez Lynch (Executive Director) and I. Glenn Cohen (Faculty Director)


Read the Full Article

From the review: 

FDA in the 21st Century is an excellent edited volume based on the Petrie–Flom Center's 2013 Annual Conference. The conference sought to gather thought leaders in academia, government, and private industry to evaluate the Agency and to make recommendations for Food and Drug Administration's (FDA's) future functioning. Peter Barton Hutt referred to it as, ‘unquestionably the largest, comprehensive symposia on food and drug law literally that has ever been held’.

Conference presenters (together with a few follow-on submitters) subsequently contributed essays to FDA in the 21st Century. The book's editors argue that their efforts are timely, given that the Agency is being faced with new challenges in the form of big data, personalized medicine, and increased globalization, together with longstanding problems related to funding, industry relations, and consumer access. Although, as a food and drug law aficionado myself, I do not think there is ever a bad time to have a book about FDA. [...] 

fda holly fernandez lynch i. glenn cohen innovation regulation